{"id":43995,"date":"2021-07-13T12:31:00","date_gmt":"2021-07-13T16:31:00","guid":{"rendered":"https:\/\/framinghamsource.com\/?p=43995"},"modified":"2021-07-13T15:14:33","modified_gmt":"2021-07-13T19:14:33","slug":"arch-therapeutics-announces-yrigoyen-as-vice-president-of-sales","status":"publish","type":"post","link":"https:\/\/framinghamsource.com\/index.php\/2021\/07\/13\/arch-therapeutics-announces-yrigoyen-as-vice-president-of-sales\/","title":{"rendered":"Arch Therapeutics Announces Yrigoyen As Vice President of sales"},"content":{"rendered":"\n<p><strong><em>In full transparency, the following press release was submitted to SOURCE media through its business wire service.<\/em><\/strong><\/p>\n\n\n\n<p>***<\/p>\n\n\n\n<p><strong>[broadstreet zone=&#8221;59945&#8243;]<\/strong><\/p>\n\n\n\n<p>FRAMINGHAM &#8211; Arch Therapeutics, a developer of novel self-assembling wound care and biosurgical devices, yesterday, July 12, announced that Dan Yrigoyen has joined the organization as Vice President of Sales. <\/p>\n\n\n\n<p>Yrigoyen will lead the Company\u2019s national commercialization effort with a focus on revenue generation and channel development.<\/p>\n\n\n\n<p>Yrigoyen has over\u00a025\u00a0years\u00a0of\u00a0healthcare experience with a proven track record of driving\u00a0business growth.\u00a0Yrigoyen\u2019s capabilities span a broad range of activities with expertise in the areas of new product launches, business process development, sales strategy, revenue generation and growth, metrics-driven performance management, and strategic partnership development.\u00a0<\/p>\n\n\n\n<p>Most recently, Yrigoyen served as Vice President, Sales &amp; Channel Distribution for Medela, Inc., a global medical device company.\u00a0Prior to that, he served as General Manager and led both domestic and international commercial initiatives at Hollister, Inc., a worldwide manufacturer of healthcare products.\u00a0<\/p>\n\n\n\n<p><strong>[broadstreet zone=&#8221;59947&#8243;]<\/strong><\/p>\n\n\n\n<p>Yrigoyen graduated with an MBA from the Kellogg School of Management at Northwestern University.\u00a0<\/p>\n\n\n\n<p>Terrence W. Norchi, M.D., Chief Executive Officer of Arch Therapeutics, said, \u201cAfter an extensive nationwide search, I am pleased to welcome Dan as the critical last piece of the new leadership team at Arch Therapeutics. His extensive medical device and wound care background and his notable accomplishments in commercial sales uniquely position him to drive our immediate and ongoing commercialization efforts. Dan is an outstanding addition to the organization, and I am confident he will provide strong leadership and results.\u201d<\/p>\n\n\n\n<p>Yrigoyen said \u201cI am beyond excited to join the leadership team at Arch Therapeutics. As an industry veteran, I know AC5\u2019s self-assembling peptide technology is a truly unique solution that outclasses the competition. I look forward to working with the entire team to build a world-class commercial organization capable of driving adoption and long-term revenue growth of both Dermal Sciences and Biosurgery products.\u201d<\/p>\n\n\n\n<p><strong>[broadstreet zone=&#8221;59948&#8243;]<\/strong><\/p>\n\n\n\n<p><strong>***<\/strong><\/p>\n\n\n\n<p><em>Arch Therapeutics, Inc. is a biotechnology company developing a novel approach to stop bleeding (hemostasis), control leaking (sealant) and manage wounds during surgery, trauma and interventional care. Arch is developing products based on an innovative self-assembling barrier technology platform with the goal of making care faster and safer for patients. Arch has received regulatory authorization to market AC5 Advanced Wound System and AC5 Topical Hemostat as medical devices in the United States and Europe, respectively. The company&#8217;s HQ is in Framingham<\/em><\/p>\n\n\n\n<p><strong>[broadstreet zone=&#8221;59982&#8243;]<\/strong><\/p>\n\n\n\n<p><\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>In full transparency, the following press release was submitted to SOURCE media through its business wire service. *** [broadstreet zone=&#8221;59945&#8243;] FRAMINGHAM &#8211; Arch Therapeutics, a developer of novel self-assembling wound care and biosurgical devices, yesterday, July 12, announced that Dan Yrigoyen has joined the organization as Vice President of Sales. Yrigoyen will lead the Company\u2019s [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":29083,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_uf_show_specific_survey":0,"_uf_disable_surveys":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"_wpas_customize_per_network":false},"categories":[9,152],"tags":[2040,12361,1613,263],"class_list":["post-43995","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business","category-health","tag-arch-therapeutics","tag-dan-yrigoyen","tag-framingham-business","tag-framingham-company"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Arch Therapeutics Announces Yrigoyen As Vice President of sales - Framingham Source<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/framinghamsource.com\/index.php\/2021\/07\/13\/arch-therapeutics-announces-yrigoyen-as-vice-president-of-sales\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Arch Therapeutics Announces Yrigoyen As Vice President of sales - Framingham Source\" \/>\n<meta property=\"og:description\" content=\"In full transparency, the following press release was submitted to SOURCE media through its business wire service. *** [broadstreet zone=&#8221;59945&#8243;] FRAMINGHAM &#8211; Arch Therapeutics, a developer of novel self-assembling wound care and biosurgical devices, yesterday, July 12, announced that Dan Yrigoyen has joined the organization as Vice President of Sales. Yrigoyen will lead the Company\u2019s [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/framinghamsource.com\/index.php\/2021\/07\/13\/arch-therapeutics-announces-yrigoyen-as-vice-president-of-sales\/\" \/>\n<meta property=\"og:site_name\" content=\"Framingham Source\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-13T16:31:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-07-13T19:14:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/framinghamsource.com\/wp-content\/uploads\/2021\/02\/archtherapeutics.courtesy.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"500\" \/>\n\t<meta property=\"og:image:height\" content=\"300\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"editor\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"editor\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/framinghamsource.com\\\/index.php\\\/2021\\\/07\\\/13\\\/arch-therapeutics-announces-yrigoyen-as-vice-president-of-sales\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/framinghamsource.com\\\/index.php\\\/2021\\\/07\\\/13\\\/arch-therapeutics-announces-yrigoyen-as-vice-president-of-sales\\\/\"},\"author\":{\"name\":\"editor\",\"@id\":\"https:\\\/\\\/framinghamsource.com\\\/#\\\/schema\\\/person\\\/d95459516e960a3f10c089ebfc8abce4\"},\"headline\":\"Arch Therapeutics Announces Yrigoyen As Vice President of sales\",\"datePublished\":\"2021-07-13T16:31:00+00:00\",\"dateModified\":\"2021-07-13T19:14:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/framinghamsource.com\\\/index.php\\\/2021\\\/07\\\/13\\\/arch-therapeutics-announces-yrigoyen-as-vice-president-of-sales\\\/\"},\"wordCount\":415,\"publisher\":{\"@id\":\"https:\\\/\\\/framinghamsource.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/framinghamsource.com\\\/index.php\\\/2021\\\/07\\\/13\\\/arch-therapeutics-announces-yrigoyen-as-vice-president-of-sales\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/framinghamsource.com\\\/wp-content\\\/uploads\\\/2021\\\/02\\\/archtherapeutics.courtesy.jpeg\",\"keywords\":[\"Arch Therapeutics\",\"Dan Yrigoyen\",\"Framingham Business\",\"Framingham Company\"],\"articleSection\":[\"Business\",\"Health\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/framinghamsource.com\\\/index.php\\\/2021\\\/07\\\/13\\\/arch-therapeutics-announces-yrigoyen-as-vice-president-of-sales\\\/\",\"url\":\"https:\\\/\\\/framinghamsource.com\\\/index.php\\\/2021\\\/07\\\/13\\\/arch-therapeutics-announces-yrigoyen-as-vice-president-of-sales\\\/\",\"name\":\"Arch Therapeutics Announces Yrigoyen As Vice President of sales - Framingham Source\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/framinghamsource.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/framinghamsource.com\\\/index.php\\\/2021\\\/07\\\/13\\\/arch-therapeutics-announces-yrigoyen-as-vice-president-of-sales\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/framinghamsource.com\\\/index.php\\\/2021\\\/07\\\/13\\\/arch-therapeutics-announces-yrigoyen-as-vice-president-of-sales\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/framinghamsource.com\\\/wp-content\\\/uploads\\\/2021\\\/02\\\/archtherapeutics.courtesy.jpeg\",\"datePublished\":\"2021-07-13T16:31:00+00:00\",\"dateModified\":\"2021-07-13T19:14:33+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/framinghamsource.com\\\/index.php\\\/2021\\\/07\\\/13\\\/arch-therapeutics-announces-yrigoyen-as-vice-president-of-sales\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/framinghamsource.com\\\/index.php\\\/2021\\\/07\\\/13\\\/arch-therapeutics-announces-yrigoyen-as-vice-president-of-sales\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/framinghamsource.com\\\/index.php\\\/2021\\\/07\\\/13\\\/arch-therapeutics-announces-yrigoyen-as-vice-president-of-sales\\\/#primaryimage\",\"url\":\"https:\\\/\\\/framinghamsource.com\\\/wp-content\\\/uploads\\\/2021\\\/02\\\/archtherapeutics.courtesy.jpeg\",\"contentUrl\":\"https:\\\/\\\/framinghamsource.com\\\/wp-content\\\/uploads\\\/2021\\\/02\\\/archtherapeutics.courtesy.jpeg\",\"width\":500,\"height\":300},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/framinghamsource.com\\\/index.php\\\/2021\\\/07\\\/13\\\/arch-therapeutics-announces-yrigoyen-as-vice-president-of-sales\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/framinghamsource.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Arch Therapeutics Announces Yrigoyen As Vice President of sales\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/framinghamsource.com\\\/#website\",\"url\":\"https:\\\/\\\/framinghamsource.com\\\/\",\"name\":\"Framingham Source\",\"description\":\"A self-publishing community bulletin board.\",\"publisher\":{\"@id\":\"https:\\\/\\\/framinghamsource.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/framinghamsource.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/framinghamsource.com\\\/#organization\",\"name\":\"Framingham Source\",\"url\":\"https:\\\/\\\/framinghamsource.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/framinghamsource.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/framinghamsource.com\\\/wp-content\\\/uploads\\\/2023\\\/01\\\/cropped-cropped-Screen-Shot-2023-01-01-at-4.19.03-PM.png\",\"contentUrl\":\"https:\\\/\\\/framinghamsource.com\\\/wp-content\\\/uploads\\\/2023\\\/01\\\/cropped-cropped-Screen-Shot-2023-01-01-at-4.19.03-PM.png\",\"width\":912,\"height\":300,\"caption\":\"Framingham Source\"},\"image\":{\"@id\":\"https:\\\/\\\/framinghamsource.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/framinghamsource.com\\\/#\\\/schema\\\/person\\\/d95459516e960a3f10c089ebfc8abce4\",\"name\":\"editor\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/813d6862cae0c7628091fcd22729e8e0914d381327330afbbd1b2f3cccebe56d?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/813d6862cae0c7628091fcd22729e8e0914d381327330afbbd1b2f3cccebe56d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/813d6862cae0c7628091fcd22729e8e0914d381327330afbbd1b2f3cccebe56d?s=96&d=mm&r=g\",\"caption\":\"editor\"},\"description\":\"Susan Petroni is the former editor for SOURCE. She is the founder of the former news site, which as of May 1, 2023, is now a self-publishing community bulletin board. The website no longer has a journalist but a webmaster.\",\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/in\\\/susan-scully-petroni-8700992\\\/\"],\"url\":\"https:\\\/\\\/framinghamsource.com\\\/index.php\\\/author\\\/editor\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Arch Therapeutics Announces Yrigoyen As Vice President of sales - Framingham Source","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/framinghamsource.com\/index.php\/2021\/07\/13\/arch-therapeutics-announces-yrigoyen-as-vice-president-of-sales\/","og_locale":"en_US","og_type":"article","og_title":"Arch Therapeutics Announces Yrigoyen As Vice President of sales - Framingham Source","og_description":"In full transparency, the following press release was submitted to SOURCE media through its business wire service. *** [broadstreet zone=&#8221;59945&#8243;] FRAMINGHAM &#8211; Arch Therapeutics, a developer of novel self-assembling wound care and biosurgical devices, yesterday, July 12, announced that Dan Yrigoyen has joined the organization as Vice President of Sales. Yrigoyen will lead the Company\u2019s [&hellip;]","og_url":"https:\/\/framinghamsource.com\/index.php\/2021\/07\/13\/arch-therapeutics-announces-yrigoyen-as-vice-president-of-sales\/","og_site_name":"Framingham Source","article_published_time":"2021-07-13T16:31:00+00:00","article_modified_time":"2021-07-13T19:14:33+00:00","og_image":[{"width":500,"height":300,"url":"https:\/\/framinghamsource.com\/wp-content\/uploads\/2021\/02\/archtherapeutics.courtesy.jpeg","type":"image\/jpeg"}],"author":"editor","twitter_card":"summary_large_image","twitter_misc":{"Written by":"editor","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/framinghamsource.com\/index.php\/2021\/07\/13\/arch-therapeutics-announces-yrigoyen-as-vice-president-of-sales\/#article","isPartOf":{"@id":"https:\/\/framinghamsource.com\/index.php\/2021\/07\/13\/arch-therapeutics-announces-yrigoyen-as-vice-president-of-sales\/"},"author":{"name":"editor","@id":"https:\/\/framinghamsource.com\/#\/schema\/person\/d95459516e960a3f10c089ebfc8abce4"},"headline":"Arch Therapeutics Announces Yrigoyen As Vice President of sales","datePublished":"2021-07-13T16:31:00+00:00","dateModified":"2021-07-13T19:14:33+00:00","mainEntityOfPage":{"@id":"https:\/\/framinghamsource.com\/index.php\/2021\/07\/13\/arch-therapeutics-announces-yrigoyen-as-vice-president-of-sales\/"},"wordCount":415,"publisher":{"@id":"https:\/\/framinghamsource.com\/#organization"},"image":{"@id":"https:\/\/framinghamsource.com\/index.php\/2021\/07\/13\/arch-therapeutics-announces-yrigoyen-as-vice-president-of-sales\/#primaryimage"},"thumbnailUrl":"https:\/\/framinghamsource.com\/wp-content\/uploads\/2021\/02\/archtherapeutics.courtesy.jpeg","keywords":["Arch Therapeutics","Dan Yrigoyen","Framingham Business","Framingham Company"],"articleSection":["Business","Health"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/framinghamsource.com\/index.php\/2021\/07\/13\/arch-therapeutics-announces-yrigoyen-as-vice-president-of-sales\/","url":"https:\/\/framinghamsource.com\/index.php\/2021\/07\/13\/arch-therapeutics-announces-yrigoyen-as-vice-president-of-sales\/","name":"Arch Therapeutics Announces Yrigoyen As Vice President of sales - Framingham Source","isPartOf":{"@id":"https:\/\/framinghamsource.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/framinghamsource.com\/index.php\/2021\/07\/13\/arch-therapeutics-announces-yrigoyen-as-vice-president-of-sales\/#primaryimage"},"image":{"@id":"https:\/\/framinghamsource.com\/index.php\/2021\/07\/13\/arch-therapeutics-announces-yrigoyen-as-vice-president-of-sales\/#primaryimage"},"thumbnailUrl":"https:\/\/framinghamsource.com\/wp-content\/uploads\/2021\/02\/archtherapeutics.courtesy.jpeg","datePublished":"2021-07-13T16:31:00+00:00","dateModified":"2021-07-13T19:14:33+00:00","breadcrumb":{"@id":"https:\/\/framinghamsource.com\/index.php\/2021\/07\/13\/arch-therapeutics-announces-yrigoyen-as-vice-president-of-sales\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/framinghamsource.com\/index.php\/2021\/07\/13\/arch-therapeutics-announces-yrigoyen-as-vice-president-of-sales\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/framinghamsource.com\/index.php\/2021\/07\/13\/arch-therapeutics-announces-yrigoyen-as-vice-president-of-sales\/#primaryimage","url":"https:\/\/framinghamsource.com\/wp-content\/uploads\/2021\/02\/archtherapeutics.courtesy.jpeg","contentUrl":"https:\/\/framinghamsource.com\/wp-content\/uploads\/2021\/02\/archtherapeutics.courtesy.jpeg","width":500,"height":300},{"@type":"BreadcrumbList","@id":"https:\/\/framinghamsource.com\/index.php\/2021\/07\/13\/arch-therapeutics-announces-yrigoyen-as-vice-president-of-sales\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/framinghamsource.com\/"},{"@type":"ListItem","position":2,"name":"Arch Therapeutics Announces Yrigoyen As Vice President of sales"}]},{"@type":"WebSite","@id":"https:\/\/framinghamsource.com\/#website","url":"https:\/\/framinghamsource.com\/","name":"Framingham Source","description":"A self-publishing community bulletin board.","publisher":{"@id":"https:\/\/framinghamsource.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/framinghamsource.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/framinghamsource.com\/#organization","name":"Framingham Source","url":"https:\/\/framinghamsource.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/framinghamsource.com\/#\/schema\/logo\/image\/","url":"https:\/\/framinghamsource.com\/wp-content\/uploads\/2023\/01\/cropped-cropped-Screen-Shot-2023-01-01-at-4.19.03-PM.png","contentUrl":"https:\/\/framinghamsource.com\/wp-content\/uploads\/2023\/01\/cropped-cropped-Screen-Shot-2023-01-01-at-4.19.03-PM.png","width":912,"height":300,"caption":"Framingham Source"},"image":{"@id":"https:\/\/framinghamsource.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/framinghamsource.com\/#\/schema\/person\/d95459516e960a3f10c089ebfc8abce4","name":"editor","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/813d6862cae0c7628091fcd22729e8e0914d381327330afbbd1b2f3cccebe56d?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/813d6862cae0c7628091fcd22729e8e0914d381327330afbbd1b2f3cccebe56d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/813d6862cae0c7628091fcd22729e8e0914d381327330afbbd1b2f3cccebe56d?s=96&d=mm&r=g","caption":"editor"},"description":"Susan Petroni is the former editor for SOURCE. She is the founder of the former news site, which as of May 1, 2023, is now a self-publishing community bulletin board. The website no longer has a journalist but a webmaster.","sameAs":["https:\/\/www.linkedin.com\/in\/susan-scully-petroni-8700992\/"],"url":"https:\/\/framinghamsource.com\/index.php\/author\/editor\/"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/framinghamsource.com\/wp-content\/uploads\/2021\/02\/archtherapeutics.courtesy.jpeg","_links":{"self":[{"href":"https:\/\/framinghamsource.com\/index.php\/wp-json\/wp\/v2\/posts\/43995","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/framinghamsource.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/framinghamsource.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/framinghamsource.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/framinghamsource.com\/index.php\/wp-json\/wp\/v2\/comments?post=43995"}],"version-history":[{"count":2,"href":"https:\/\/framinghamsource.com\/index.php\/wp-json\/wp\/v2\/posts\/43995\/revisions"}],"predecessor-version":[{"id":43997,"href":"https:\/\/framinghamsource.com\/index.php\/wp-json\/wp\/v2\/posts\/43995\/revisions\/43997"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/framinghamsource.com\/index.php\/wp-json\/wp\/v2\/media\/29083"}],"wp:attachment":[{"href":"https:\/\/framinghamsource.com\/index.php\/wp-json\/wp\/v2\/media?parent=43995"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/framinghamsource.com\/index.php\/wp-json\/wp\/v2\/categories?post=43995"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/framinghamsource.com\/index.php\/wp-json\/wp\/v2\/tags?post=43995"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}